Cargando…
The 5-HT(1B) receptor - a potential target for antidepressant treatment
Major depressive disorder (MDD) is the leading cause of disability worldwide. The serotonin hypothesis may be the model of MDD pathophysiology with the most support. The majority of antidepressants enhance synaptic serotonin levels quickly, while it usually takes weeks to discern MDD treatment effec...
Autores principales: | Tiger, Mikael, Varnäs, Katarina, Okubo, Yoshiro, Lundberg, Johan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919989/ https://www.ncbi.nlm.nih.gov/pubmed/29546551 http://dx.doi.org/10.1007/s00213-018-4872-1 |
Ejemplares similares
-
Serotonin 1B receptor density mapping of the human brainstem using
positron emission tomography and autoradiography
por: Veldman, Emma R, et al.
Publicado: (2021) -
Plasma Levels of Brain-Derived Neurotrophic Factor and S100B in Relation to Antidepressant Response to Ketamine
por: Jiang, Haitang, et al.
Publicado: (2021) -
5-HT Receptors and the Development of New Antidepressants
por: Ślifirski, Grzegorz, et al.
Publicado: (2021) -
Associations Between Cognition and Serotonin 1B Receptor Availability in Healthy Volunteers: A [(11)C]AZ10419369 Positron Emission Tomography Study
por: Tangen, Ämma, et al.
Publicado: (2022) -
Role of 5-HT(3) Receptors in the Antidepressant Response
por: Bétry, Cécile, et al.
Publicado: (2011)